Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents
Cong-Min Penga,
Shih-Wei Wangbcd,
Yi-Lin Hwanga,
Wen-Chun Sunbe,
Li-Pin Chiufg,
Yi-Ting Liua,
Yu-Wei Lai*hi and
Hsueh-Yun Lee*ajk
aSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. E-mail: hyl@tmu.edu.tw
bInstitute of Biomedical Sciences, MacKay Medical College, New Taipei City, Taiwan
cDepartment of Medicine, MacKay Medical College, New Taipei City, Taiwan
dSchool of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
eDivision of Colon and Rectal Surgery, Department of Surgery, MacKay Memorial Hospital, Taipei, Taiwan
fDivision of General Surgery, Taipei City Hospital Chushing Branch, Taipei, Taiwan
gGeneral Education Center, University of Taipei, Taipei, Taiwan
hDivision of Urology, Taipei City Hospital Renai Branch, Taipei, Taiwan. E-mail: dai77@tpech.gov.tw
iDepartment of Urology, School of Medicine and Shu-Tien Urological Science Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
jPhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
kTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan
First published on 16th May 2023
Abstract
Correction for ‘CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents’ by Cong-Min Peng et al., RSC Adv., 2023, 13, 13169–13176, https://doi.org/10.1039/D3RA01927F.
The authors regret that the one of the affiliations (affiliation h) was incorrectly shown in the original manuscript. The corrected list of affiliations is as shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |